Related Experiment Video
Updated: Oct 18, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
A score system to predict no-reflow in primary percutaneous coronary intervention: The PIANO Score
Chunfeng Dai1,2, Muyin Liu1,2, You Zhou1,2
1Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.
Insights
A new PIANO score predicts angiographic no-reflow in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary PCI. This tool helps identify high-risk individuals for tailored treatment strategies.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Risk Prediction
Background:
- Angiographic no-reflow is a significant predictor of poor outcomes in STEMI patients.
- Primary percutaneous coronary intervention (PCI) is the standard reperfusion therapy for STEMI.
Purpose of the Study:
- To develop and validate a predictive score for angiographic no-reflow in STEMI patients undergoing primary PCI.
- To identify key clinical predictors of no-reflow phenomenon.
Main Methods:
- A predictive score, the PIANO score, was developed using logistic regression in a training set of STEMI patients undergoing primary PCI.
- Independent predictors were identified, and the score was validated for discrimination and calibration.
Main Results:
- The PIANO score incorporates six clinical variables: age, absence of pre-infarction angina, ischemic time, culprit artery, pre-PCI TIMI flow, and pre-PCI thrombus score.
- The PIANO score demonstrated good predictive performance (concordance index of 0.857) and calibration, distinguishing high-risk from low-risk patients.
Conclusions:
- The validated PIANO score effectively predicts angiographic no-reflow in STEMI patients undergoing primary PCI.
- This score can aid in selecting optimal, individualized treatment strategies for STEMI management.
Background:
Angiographic no-reflow is associated with poor outcomes in patients with ST-segment elevation myocardial infarction (STEMI). We sought to develop and validate a score system to predict angiographic no-reflow in primary percutaneous coronary intervention (PCI).
Methods:
ST-segment elevation myocardial infarction patients undergoing primary PCI were consecutively enrolled and were randomly divided into the training and validation set. Angiographic no-reflow was defined as thrombolysis in myocardial infarction (TIMI) flow grade 0 to 2 after PCI. In the training set, independent predictors were identified by logistic regression analysis, and a score system (PredIction of Angiographic NO-reflow, the PIANO score) was constructed based on the β-coefficient of each variable. The established model was evaluated for discrimination and calibration.
Results:
Angiographic no-reflow occurred in 362 (17.8%) of 2036 patients. Age ≥70 years, absence of pre-infarction angina, total ischaemic time ≥4 h, left anterior descending as culprit artery, pre-PCI TIMI flow grade ≤1 and pre-PCI TIMI thrombus score ≥4 were independent predictors of angiographic no-reflow. The PIANO score ranged from 0 to 14 points, yielding a concordance index of 0.857 (95% confidence interval: 0.833 to 0.880), with good calibration. In the high-risk (≥8 points) group, the probability of angiographic no-reflow phenomenon was 38.7%, while it was only 4.8% in the low-risk (<8 points) group. The score system performed well in the validation set.
Conclusions:
We establish and validate a score system based on six clinical variables to predict angiographic no-reflow in STEMI patients undergoing primary PCI, which may help choose the optimal individual treatment strategy.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023